Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590

Guangdi Li; Yali Wang; Erik De Clercq

doi:10.1016/j.apsb.2023.06.004

Guangdi Li, Yali Wang, Erik De Clercq. Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590J. Acta Pharmaceutica Sinica B, 2023, 13(8): 3581-3581. DOI: 10.1016/j.apsb.2023.06.004

Citation:

Guangdi Li, Yali Wang, Erik De Clercq. Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590J. Acta Pharmaceutica Sinica B, 2023, 13(8): 3581-3581. DOI: 10.1016/j.apsb.2023.06.004

Citation:

Guangdi Li, Yali Wang, Erik De Clercq. Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590J. Acta Pharmaceutica Sinica B, 2023, 13(8): 3581-3581. DOI: 10.1016/j.apsb.2023.06.004

Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590

Abstract

FullText(HTML)

References (0)

Relative Articles

Supplements (0)

Cited By

/

DownLoad: Full-Size Img PowerPoint

Return

Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ Acta Pharmaceutica Sinica B 12 (2022) 1567–1590

Catalog

Export File

Citation

Format

Content